Teleflex reported 2025 compensation for top executives, including two who left after the medtech CDMO sold off some big ...

Investors in Teleflex Incorporated TFX need to pay close attention to the stock based on moves in the options market lately. That is because the July 17, 2026 $90.00 Call had some of the highest ...

Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two separate deals totalling over $2bn as part of the company's broader portfolio ...

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the beginning of ...

View Teleflex Incorporated TFX stock quote prices, financial information, real-time forecasts, and company news from CNN.

Teleflex has struck a $260 million deal to buy IWG High Performance Conductors as it looks to build on a financial year in which it beat expectations. In fourth quarter results posted Thursday, ...

Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com. Teleflex is the home of Arrow ®, Deknatel ®, ...

Teleflex TFX posted solid fourth-quarter performance, ending the year on a stable note. On one hand, currency was a major headwind across all segments this fiscal year, and supply chain and staffing ...

The latest price target for Teleflex (NYSE:TFX) was reported by Piper Sandler on June 8, 2026. The analyst firm set a price target for $160.00 expecting TFX to rise to within 12 months (a possible ...

Teleflex Incorporated (NYSE: TFX) today announced that Jason Weidman has been appointed President and Chief Executive Officer, effective June 8, 2026. He will succeed Stuart Randle, who has been ...

Teleflex’s independent directors approved on June 8, 2026 a special restricted stock unit award with a grant date fair value of $600,000 for Stuart A. Randle, recognizing his significant contributions ...

Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, ...